BGI
GPCR icon

B Group Inc’s Structure Therapeutics GPCR Stock Holding History

B Group Inc’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.15M Buy
127,500
+37,500
+42% +$2.57M 4.56% 8
2025
Q4 		$6.26M Buy
+90,000
New +$3.67M 4.62% 8

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

B Group Inc's GPCR Position: Q1 2026 in Review

B Group Inc increased its Structure Therapeutics (GPCR) stake by 42% in Q1 2026, buying an estimated $2.57M and bringing the position to 127,500 shares worth $6.15M. The position accounts for 4.56% of the portfolio, ranked #8.

B Group Inc first reported a position in GPCR in Q4 2025 and has held it in 2 quarters since. The position peaked at $6.26M in Q4 2025. 196 funds tracked by Wall St. Rank hold GPCR as of Q1 2026.

  • B Group Inc held 127,500 shares of Structure Therapeutics worth $6.15M as of Q1 2026.
  • B Group Inc bought 37,500 Structure Therapeutics shares in Q1 2026, an estimated $2.57M.
  • Structure Therapeutics made up 4.56% of B Group Inc's portfolio in Q1 2026, its #8 holding.
  • B Group Inc first reported a position in Structure Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • B Group Inc's Structure Therapeutics position peaked at $6.26M in Q4 2025.
  • 196 funds tracked by Wall St. Rank held Structure Therapeutics as of Q1 2026.

Based on B Group Inc's 13F filing for Q1 2026, filed 15 May 2026.